Global Cas12-Based Molecular Diagnostics Market Set to Witness Robust Growth
The global Cas12-Based Molecular Diagnostics market is emerging as a transformative segment within the diagnostics and biotech industry, driven by the increasing adoption of CRISPR-based technologies for precise and rapid pathogen detection. Valued at USD 520 million in 2023, the market is projected to reach USD 1.2 billion by 2032, growing at a CAGR of 9.2% during the forecast period. The rising prevalence of infectious diseases, coupled with the demand for point-of-care testing and high-accuracy molecular diagnostics, is fueling global market expansion.